Article
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status.
Acta neuropathologica - 1 Oct 2012
Bady Pierre, Sciuscio Davide, Diserens Annie-Claire, Bloch Jocelyne, van den Bent Martin J, Marosi Christine, Dietrich Pierre-Yves, Weller Michael, Mariani Luigi, Heppner Frank L, Mcdonald David R, Lacombe Denis, Stupp Roger, Delorenzi Mauro, Hegi Monika E
Abstract excerpt
The methylation status of the O(6)-methylguanine-DNA methyltransferase (MGMT) gene is an important predictive biomarker for benefit from alkylating agent therapy in glioblastoma. Recent studies in anaplastic glioma suggest a prognostic value for MGMT methylation. Investigation of pathogenetic and epigenetic features of this intriguingly distinct behavior requires accurate MGMT classification to assess high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.